Mammographic calcifications account for 31 % of recalled lesions in digital screening mammography, representing 0.4–2 % of all women undergoing mammographic screening[1,2]. However, approximately 50–80 % of these lesions are benign [2,3]. When malignant, about 66 % are confirmed as ductal carcinoma in situ (DCIS) [4]. As such, mammographic calcifications account for about 80 % of DCIS diagnoses [5,6]. DCIS is the most controversial breast malignancy diagnosed in women, as pure DCIS is non-lethal…